Select Page

INBRAIN Neuroelectronics announces FDA Breakthrough Device Designation for Its Graphene-Based Intelligent Network Modulation Platform

INBRAIN Neuroelectronics, a health-tech company dedicated to developing intelligent graphene-neural platform, has announced that its Intelligent Network Modulation System has been granted Breakthrough Device Designation (BDD) from the U.S. Food & Drug...